$THRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Innoviva, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Innoviva, Inc.. Get notifications about new insider transactions in Innoviva, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 23 2015 | THRX | Innoviva, Inc. | dEsparbes Eric | SVP and CFO | Payment of Exercise | F | 8.92 | 7,940 | 70,825 | 132,779 | 140.7 K to 132.8 K (-5.64 %) |
Aug 07 2015 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 3,485,840.00 | 245,828 | 856,917,331,181 | 32,005,260 | 31.8 M to 32 M (+0.77 %) |
Jul 27 2015 | THRX | Innoviva, Inc. | Faerm Michael E. | Sr VP & Chief Busin ... | Grant | A | 0.00 | 105,288 | 0 | 105,288 | 0 to 105.3 K |
Jun 04 2015 | THRX | Innoviva, Inc. | Aguiar Michael W | President & CEO | Payment of Exercise | F | 16.68 | 24,698 | 411,963 | 432,653 | 457.4 K to 432.7 K (-5.40 %) |
Jun 04 2015 | THRX | Innoviva, Inc. | Tyree James L | Director | Sell | S | 16.85 | 2,438 | 41,080 | 33,182 | 35.6 K to 33.2 K (-6.84 %) |
May 29 2015 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Option Exercise | M | 13.45 | 16,313 | 219,410 | 0 | |
May 29 2015 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Sell | S | 16.32 | 16,313 | 266,228 | 123,604 | 139.9 K to 123.6 K (-11.66 %) |
May 29 2015 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Buy | M | 13.45 | 16,313 | 219,410 | 139,917 | 123.6 K to 139.9 K (+13.20 %) |
May 22 2015 | THRX | Innoviva, Inc. | Aguiar Michael W | President & CEO | Payment of Exercise | F | 16.24 | 3,256 | 52,877 | 457,351 | 460.6 K to 457.4 K (-0.71 %) |
May 11 2015 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 1,369,260.00 | 85,579 | 117,180,243,856 | 31,759,432 | 31.7 M to 31.8 M (+0.27 %) |
Apr 27 2015 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Grant | A | 0.00 | 13,950 | 0 | 117,264 | 103.3 K to 117.3 K (+13.50 %) |
Apr 27 2015 | THRX | Innoviva, Inc. | Kearney Terrence C | Director | Grant | A | 0.00 | 13,950 | 0 | 37,083 | 23.1 K to 37.1 K (+60.30 %) |
Apr 27 2015 | THRX | Innoviva, Inc. | FRIEDMAN CATHY | Director | Grant | A | 0.00 | 13,950 | 0 | 35,620 | 21.7 K to 35.6 K (+64.37 %) |
Apr 27 2015 | THRX | Innoviva, Inc. | PEPE PAUL | Director | Grant | A | 0.00 | 13,950 | 0 | 35,620 | 21.7 K to 35.6 K (+64.37 %) |
Apr 27 2015 | THRX | Innoviva, Inc. | Tyree James L | Director | Grant | A | 0.00 | 13,950 | 0 | 35,620 | 21.7 K to 35.6 K (+64.37 %) |
Mar 02 2015 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 1,673,690.00 | 92,674 | 155,107,773,185 | 31,673,853 | 31.6 M to 31.7 M (+0.29 %) |
Feb 24 2015 | THRX | Innoviva, Inc. | Aguiar Michael W | President & CEO | Payment of Exercise | F | 18.22 | 6,789 | 123,696 | 446,148 | 452.9 K to 446.1 K (-1.50 %) |
Jan 09 2015 | THRX | Innoviva, Inc. | WITEK THEODORE L JR | Sr. VP, Corp Partne ... | Grant | A | 0.00 | 71,429 | 0 | 71,429 | 0 to 71.4 K |
Jan 09 2015 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP, Corp. Partn ... | Grant | A | 0.00 | 71,429 | 0 | 81,429 | 10 K to 81.4 K (+714.29 %) |
Jan 09 2015 | THRX | Innoviva, Inc. | Aguiar Michael W | President & CEO | Grant | A | 0.00 | 176,056 | 0 | 464,896 | 288.8 K to 464.9 K (+60.95 %) |
Jan 09 2015 | THRX | Innoviva, Inc. | dEsparbes Eric | SVP and CFO | Grant | A | 0.00 | 36,972 | 0 | 139,443 | 102.5 K to 139.4 K (+36.08 %) |
Dec 23 2014 | THRX | Innoviva, Inc. | Tyree James L | Director | Grant | A | 0.00 | 6,500 | 0 | 21,670 | 15.2 K to 21.7 K (+42.85 %) |
Dec 23 2014 | THRX | Innoviva, Inc. | PEPE PAUL | Director | Grant | A | 0.00 | 6,500 | 0 | 21,670 | 15.2 K to 21.7 K (+42.85 %) |
Dec 23 2014 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Grant | A | 0.00 | 3,250 | 0 | 103,314 | 100.1 K to 103.3 K (+3.25 %) |
Dec 23 2014 | THRX | Innoviva, Inc. | FRIEDMAN CATHY | Director | Grant | A | 0.00 | 6,500 | 0 | 21,670 | 15.2 K to 21.7 K (+42.85 %) |
Nov 04 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 12,786,500.00 | 832,456 | 10,644,218,756,137 | 31,581,179 | 30.7 M to 31.6 M (+2.71 %) |
Nov 03 2014 | THRX | Innoviva, Inc. | Kearney Terrence C | Director | Grant | A | 0.00 | 23,133 | 0 | 23,133 | 0 to 23.1 K |
Oct 17 2014 | THRX | Innoviva, Inc. | dEsparbes Eric | SVP and CFO | Grant | A | 0.00 | 102,471 | 0 | 102,471 | 0 to 102.5 K |
Aug 22 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 22.76 | 3,261 | 74,220 | 262,198 | 265.5 K to 262.2 K (-1.23 %) |
Aug 22 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 22.76 | 3,261 | 74,220 | 334,040 | 337.3 K to 334 K (-0.97 %) |
Aug 22 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 22.76 | 3,261 | 74,220 | 443,013 | 446.3 K to 443 K (-0.73 %) |
Aug 19 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Director | Sell | D | 0.00 | 96,250 | 0 | 825,391 | 921.6 K to 825.4 K (-10.44 %) |
Aug 22 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 22.76 | 3,261 | 74,220 | 401,538 | 404.8 K to 401.5 K (-0.81 %) |
Aug 19 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | President & CEO | Grant | A | 0.00 | 43,905 | 0 | 288,840 | 244.9 K to 288.8 K (+17.93 %) |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Option Exercise | M | 12.66 | 23,705 | 300,105 | 0 | |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Option Exercise | M | 12.66 | 24,338 | 308,119 | 0 | |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Option Exercise | M | 14.53 | 12,516 | 181,857 | 0 | |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Option Exercise | M | 9.81 | 13,882 | 136,182 | 0 | |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Sell | S | 22.50 | 53,424 | 1,202,040 | 265,459 | 318.9 K to 265.5 K (-16.75 %) |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Buy | M | 12.66 | 23,705 | 300,105 | 318,883 | 295.2 K to 318.9 K (+8.03 %) |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Buy | M | 12.66 | 24,338 | 308,119 | 295,178 | 270.8 K to 295.2 K (+8.99 %) |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Buy | M | 14.53 | 12,516 | 181,857 | 270,840 | 258.3 K to 270.8 K (+4.85 %) |
Aug 15 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Buy | M | 9.81 | 13,882 | 136,182 | 258,324 | 244.4 K to 258.3 K (+5.68 %) |
Aug 13 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Option Exercise | M | 14.53 | 33,667 | 489,182 | 0 | |
Aug 13 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Sell | S | 22.30 | 1,048 | 23,370 | 446,274 | 447.3 K to 446.3 K (-0.23 %) |
Aug 13 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Sell | S | 22.12 | 27,108 | 599,629 | 447,322 | 474.4 K to 447.3 K (-5.71 %) |
Aug 13 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Buy | M | 14.53 | 33,667 | 489,182 | 474,430 | 440.8 K to 474.4 K (+7.64 %) |
Aug 11 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 3,912,270.00 | 172,651 | 675,457,614,371 | 30,748,723 | 30.6 M to 30.7 M (+0.56 %) |
Jul 28 2014 | THRX | Innoviva, Inc. | WITEK THEODORE L JR | Sr. VP, Corp Partne ... | Option Exercise | A | 23.88 | 125,000 | 2,985,000 | 125,000 | |
Jun 23 2014 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP, Corp. Partn ... | Option Exercise | A | 29.32 | 100,000 | 2,932,000 | 100,000 | |
Jun 23 2014 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP, Corp. Partn ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jun 18 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 62,403 | 0 | 921,641 | 859.2 K to 921.6 K (+7.26 %) |
Jun 18 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 28,365 | 0 | 440,763 | 412.4 K to 440.8 K (+6.88 %) |
Jun 18 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 28,365 | 0 | 337,301 | 308.9 K to 337.3 K (+9.18 %) |
Jun 18 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 19,855 | 0 | 244,442 | 224.6 K to 244.4 K (+8.84 %) |
Jun 18 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 28,365 | 0 | 404,799 | 376.4 K to 404.8 K (+7.54 %) |
Jun 18 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 28,365 | 0 | 244,935 | 216.6 K to 244.9 K (+13.10 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | PEPE PAUL | Director | Option Exercise | A | 23.08 | 6,000 | 138,472 | 6,000 | |
Jun 04 2014 | THRX | Innoviva, Inc. | PEPE PAUL | Director | Option Exercise | A | 23.08 | 6,000 | 138,472 | 6,000 | |
Jun 04 2014 | THRX | Innoviva, Inc. | PEPE PAUL | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | PEPE PAUL | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Jun 04 2014 | THRX | Innoviva, Inc. | Tyree James L | Director | Option Exercise | A | 23.08 | 6,000 | 138,472 | 6,000 | |
Jun 04 2014 | THRX | Innoviva, Inc. | Tyree James L | Director | Option Exercise | A | 23.08 | 6,000 | 138,472 | 6,000 | |
Jun 04 2014 | THRX | Innoviva, Inc. | Tyree James L | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Tyree James L | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Jun 04 2014 | THRX | Innoviva, Inc. | FRIEDMAN CATHY | Director | Option Exercise | A | 23.08 | 6,000 | 138,472 | 6,000 | |
Jun 04 2014 | THRX | Innoviva, Inc. | FRIEDMAN CATHY | Director | Option Exercise | A | 23.08 | 6,000 | 138,472 | 6,000 | |
Jun 04 2014 | THRX | Innoviva, Inc. | FRIEDMAN CATHY | Director | Grant | A | 0.00 | 6,000 | 0 | 12,000 | 6 K to 12 K (+100.00 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | FRIEDMAN CATHY | Director | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Jun 04 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 46,200 | 0 | 859,238 | 813 K to 859.2 K (+5.68 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 110,000 | 0 | 813,038 | 703 K to 813 K (+15.65 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 21,000 | 0 | 412,398 | 391.4 K to 412.4 K (+5.37 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 50,000 | 0 | 391,398 | 341.4 K to 391.4 K (+14.65 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 21,000 | 0 | 308,936 | 287.9 K to 308.9 K (+7.29 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 50,000 | 0 | 287,936 | 237.9 K to 287.9 K (+21.01 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 14,700 | 0 | 224,587 | 209.9 K to 224.6 K (+7.00 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 50,000 | 0 | 209,887 | 159.9 K to 209.9 K (+31.27 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 21,000 | 0 | 376,434 | 355.4 K to 376.4 K (+5.91 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 50,000 | 0 | 355,434 | 305.4 K to 355.4 K (+16.37 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 21,000 | 0 | 216,570 | 195.6 K to 216.6 K (+10.74 %) |
Jun 04 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 50,000 | 0 | 195,570 | 145.6 K to 195.6 K (+34.35 %) |
May 27 2014 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Grant | A | 0.00 | 6,000 | 0 | 83,935 | 77.9 K to 83.9 K (+7.70 %) |
May 27 2014 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Grant | A | 0.00 | 6,000 | 0 | 606,377 | 600.4 K to 606.4 K (+1.00 %) |
May 27 2014 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Grant | A | 0.00 | 6,000 | 0 | 100,064 | 94.1 K to 100.1 K (+6.38 %) |
May 27 2014 | THRX | Innoviva, Inc. | RINGROSE PETER S | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | RINGROSE PETER S | Director | Grant | A | 0.00 | 6,000 | 0 | 36,000 | 30 K to 36 K (+20.00 %) |
May 27 2014 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Gift | G | 0.00 | 1,000 | 0 | 40,000 | 41 K to 40 K (-2.44 %) |
May 27 2014 | THRX | Innoviva, Inc. | MALKIEL BURTON G | Director | Grant | A | 0.00 | 6,000 | 0 | 41,000 | 35 K to 41 K (+17.14 %) |
May 27 2014 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Grant | A | 0.00 | 6,000 | 0 | 115,970 | 110 K to 116 K (+5.46 %) |
May 27 2014 | THRX | Innoviva, Inc. | Fore Henrietta | Director | Option Exercise | A | 28.54 | 6,000 | 171,240 | 6,000 | |
May 27 2014 | THRX | Innoviva, Inc. | Fore Henrietta | Director | Grant | A | 0.00 | 6,000 | 0 | 33,000 | 27 K to 33 K (+22.22 %) |
May 19 2014 | THRX | Innoviva, Inc. | THERAVANCE INC | 10% Owner | Sell | J | 0.00 | 33,100,000 | 0 | 0 | 33.1 M to 0 (-100.00 %) |
May 13 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 8,544,840.00 | 317,770 | 2,715,292,313,281 | 30,576,072 | 30.3 M to 30.6 M (+1.05 %) |
May 12 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 26.86 | 50,225 | 1,349,044 | 703,038 | 753.3 K to 703 K (-6.67 %) |
May 12 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 26.86 | 22,833 | 613,294 | 341,398 | 364.2 K to 341.4 K (-6.27 %) |
May 12 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Gift | G | 0.00 | 1,200 | 0 | 237,936 | 239.1 K to 237.9 K (-0.50 %) |
May 12 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 26.86 | 22,833 | 613,294 | 239,136 | 262 K to 239.1 K (-8.72 %) |
May 12 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 26.86 | 14,650 | 393,499 | 159,887 | 174.5 K to 159.9 K (-8.39 %) |
May 12 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 26.86 | 21,405 | 574,938 | 145,570 | 167 K to 145.6 K (-12.82 %) |
May 12 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 26.86 | 18,849 | 506,284 | 305,434 | 324.3 K to 305.4 K (-5.81 %) |
Apr 29 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Grant | A | 0.00 | 82,500 | 0 | 753,263 | 670.8 K to 753.3 K (+12.30 %) |
Apr 29 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Grant | A | 0.00 | 37,500 | 0 | 364,231 | 326.7 K to 364.2 K (+11.48 %) |
Apr 29 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Grant | A | 0.00 | 37,500 | 0 | 261,969 | 224.5 K to 262 K (+16.71 %) |
Apr 29 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 26,250 | 0 | 174,537 | 148.3 K to 174.5 K (+17.70 %) |
Apr 29 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Grant | A | 0.00 | 37,500 | 0 | 324,283 | 286.8 K to 324.3 K (+13.08 %) |
Apr 29 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Grant | A | 0.00 | 37,500 | 0 | 166,975 | 129.5 K to 167 K (+28.96 %) |
Apr 21 2014 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Option Exercise | M | 9.69 | 25,806 | 249,996 | 0 | |
Apr 21 2014 | THRX | Innoviva, Inc. | Gunderson Robert V JR | Director | Buy | M | 9.69 | 25,806 | 249,996 | 109,970 | 84.2 K to 110 K (+30.66 %) |
Apr 09 2014 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Option Exercise | M | 9.69 | 25,806 | 249,996 | 0 | |
Apr 09 2014 | THRX | Innoviva, Inc. | YOUNG WILLIAM D | Director | Buy | M | 9.69 | 25,806 | 249,996 | 77,935 | 52.1 K to 77.9 K (+49.50 %) |
Apr 02 2014 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Option Exercise | M | 9.69 | 25,806 | 249,996 | 0 | |
Apr 02 2014 | THRX | Innoviva, Inc. | WALTRIP WILLIAM H | Director | Buy | M | 9.69 | 25,806 | 249,996 | 94,064 | 68.3 K to 94.1 K (+37.81 %) |
Mar 25 2014 | THRX | Innoviva, Inc. | LEVINE ARNOLD J | Director | Option Exercise | M | 9.69 | 25,806 | 249,996 | 0 | |
Mar 25 2014 | THRX | Innoviva, Inc. | LEVINE ARNOLD J | Director | Buy | M | 9.69 | 25,806 | 249,996 | 111,794 | 86 K to 111.8 K (+30.01 %) |
Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 16.00 | 29,250 | 468,000 | 0 | |
Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Option Exercise | M | 12.40 | 12,903 | 159,997 | 0 | |
Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 16.00 | 29,250 | 468,000 | 224,469 | 195.2 K to 224.5 K (+14.98 %) |
Mar 10 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Buy | M | 12.40 | 12,903 | 159,997 | 195,219 | 182.3 K to 195.2 K (+7.08 %) |
Mar 10 2014 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Option Exercise | M | 9.69 | 25,806 | 249,996 | 0 | |
Mar 10 2014 | THRX | Innoviva, Inc. | WHITESIDES GEORGE M | Director | Buy | M | 9.69 | 25,806 | 249,996 | 600,377 | 574.6 K to 600.4 K (+4.49 %) |
Mar 05 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Option Exercise | M | 9.69 | 65,806 | 637,496 | 0 | |
Mar 05 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Option Exercise | M | 9.69 | 30,967 | 299,993 | 0 | |
Mar 05 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Sell | S | 37.23 | 1,800 | 67,014 | 326,731 | 328.5 K to 326.7 K (-0.55 %) |
Mar 05 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Sell | S | 36.72 | 64,006 | 2,350,300 | 328,531 | 392.5 K to 328.5 K (-16.31 %) |
Mar 05 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Buy | M | 9.69 | 65,806 | 637,496 | 392,537 | 326.7 K to 392.5 K (+20.14 %) |
Mar 05 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Buy | M | 9.69 | 30,967 | 299,993 | 326,731 | 295.8 K to 326.7 K (+10.47 %) |
Feb 24 2014 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 39.98 | 9,297 | 371,694 | 670,763 | 680.1 K to 670.8 K (-1.37 %) |
Feb 24 2014 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 39.98 | 4,310 | 172,314 | 295,764 | 300.1 K to 295.8 K (-1.44 %) |
Feb 24 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 39.98 | 4,307 | 172,194 | 182,316 | 186.6 K to 182.3 K (-2.31 %) |
Feb 24 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Payment of Exercise | F | 39.98 | 3,854 | 154,083 | 148,287 | 152.1 K to 148.3 K (-2.53 %) |
Feb 24 2014 | THRX | Innoviva, Inc. | BLUM LEONARD M | Sr VP, Chief Comm. ... | Payment of Exercise | F | 39.98 | 4,311 | 172,354 | 286,783 | 291.1 K to 286.8 K (-1.48 %) |
Feb 24 2014 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 39.98 | 4,302 | 171,994 | 129,475 | 133.8 K to 129.5 K (-3.22 %) |
Feb 19 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 40.04 | 4,600 | 184,184 | 186,623 | 191.2 K to 186.6 K (-2.41 %) |
Feb 19 2014 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Sell | S | 39.26 | 30,400 | 1,193,504 | 191,223 | 221.6 K to 191.2 K (-13.72 %) |
Feb 13 2014 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 12,850,700.00 | 342,229 | 4,397,881,850,960 | 30,258,302 | 29.9 M to 30.3 M (+1.14 %) |
Jan 27 2014 | THRX | Innoviva, Inc. | PASQUALONE FRANK | Sr. Vice President, ... | Option Exercise | A | 38.24 | 150,000 | 5,736,000 | 150,000 | |
Jan 27 2014 | THRX | Innoviva, Inc. | PASQUALONE FRANK | Sr. Vice President, ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Jan 27 2014 | THRX | Innoviva, Inc. | LEE JUNNING | Sr. VP, Technical O ... | Grant | A | 0.00 | 11,000 | 0 | 152,141 | 141.1 K to 152.1 K (+7.79 %) |
Nov 22 2013 | THRX | Innoviva, Inc. | Winningham Rick E | Chief Executive Off ... | Payment of Exercise | F | 36.40 | 10,046 | 365,674 | 680,060 | 690.1 K to 680.1 K (-1.46 %) |
Nov 22 2013 | THRX | Innoviva, Inc. | Shafer Bradford J | Sr VP, Gen. Counsel ... | Payment of Exercise | F | 36.40 | 4,569 | 166,312 | 300,074 | 304.6 K to 300.1 K (-1.50 %) |
Nov 22 2013 | THRX | Innoviva, Inc. | Mammen Mathai | SVP, Research & Ear ... | Payment of Exercise | F | 36.40 | 4,569 | 166,312 | 222,073 | 226.6 K to 222.1 K (-2.02 %) |
Nov 22 2013 | THRX | Innoviva, Inc. | Aguiar Michael W | Sr VP, Chief Financ ... | Payment of Exercise | F | 36.40 | 4,569 | 166,312 | 133,777 | 138.3 K to 133.8 K (-3.30 %) |
Oct 29 2013 | THRX | Innoviva, Inc. | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 4,913,610.00 | 130,473 | 641,093,852,434 | 29,916,073 | 29.8 M to 29.9 M (+0.44 %) |
Oct 24 2013 | THRX | Innoviva, Inc. | JONKER JEFFREY DAVID | Senior VP, Corp. & ... | Option Exercise | A | 36.30 | 150,000 | 5,445,000 | 150,000 | |
Oct 24 2013 | THRX | Innoviva, Inc. | JONKER JEFFREY DAVID | Senior VP, Corp. & ... | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |